Tags » ADT

Lowering risk of death from prostate cancer AND cardiovascular disease

Based on a specific case study, a new paper in Circulation by a group of clinicians at Vanderbilt University Medical Center describes their program designed to reduce risk of death from cardiovascular disease for prostate cancer patients on androgen deprivation therapy (ADT). 359 more words

Risk

Abstract data types vs Data structures

C++ data structures is another course am learning this semester. This course is a pre-requisite for all non-Computer Science students. I have already learnt and implemented all the C++ data structures in a private course during my undergraduate studies, but not with the same understanding am learning them these days. 338 more words

Data Structures

Home Security and Safety on Decks and Patios This Summer

Keep up with regular maintenance. Whenever you notice a potential danger around or on your deck or patio, make sure to take care of it right away. 506 more words

EBRT works better with ADT for intermediate- and high-risk prostate cancer

The EORTC trial 22991 was designed and implemented to compare external beam radiation therapy (EBRT) + short-term androgen deprivation therapy (ADT) to EBRT alone as first-line therapy in patients with intermediate- and high-risk prostate cancer. 422 more words

Management

Quality of life data and the CHAARTED trial

As regular readers will be aware, the data from the CHAARTED trial were the first to show that combining androgen deprivation (ADT) with docetaxel chemotherapy has a significant, life-extending benefit in at least some men newly diagnosed with metastatic prostate cancer. 444 more words

Management

8 January 2016

FRIDAY FICTION CONCRIT SUBGROUP

If you want to be part of this group click the link above and follow the rules set forth by Jennifer Pendergast, the leader of this subgroup. 170 more words

Friday Fictioneers

Prostate cancer, cardiovascular disease, and the role of ADT

A new trial to be discussed at the Genitourinary Cancers Symposium is the RADICAL-PC trial, designed to give us a greater understanding of the roles of androgen deprivation (ADT) and other factors in causing cardiovascular disease in high-risk prostate cancer patients. 324 more words

Management